Jinbo Bio-pharmaceutical

China-based Shanxi Jinbo Bio-pharmaceutical Co., Ltd. (832982.BSE) is poised to raise RMB 36.75 million through a private placement on the Beijing Stock Exchange, supplementing the RMB 245 million initial public offering (IPO) proceeds the company recently acquired. Jinbo Bio’s Industrialization of Recombinant Collagen ProteinFounded in 2008, Jinbo Bio has achieved…